Investigation on Intestinal Proteins and Drug Metabolizing Enzymes in Simulated Microgravity Rats by a Proteomics Method

Abstract

The present study aimed to investigate the change of intestinal mucosa proteins, especially the alteration of intestinal drug metabolizing enzymes (IDMEs) following 14-day simulated microgravity. Morey–Holton tail-suspension analog was used to simulate microgravity. Intestinal mucosa proteins of rats were determined by label-free quantitative proteomic strategy. A total of 335 differentially expressed proteins (DEPs) were identified, 190 DEPs were upregulated, and 145 DEPs were downregulated. According to bioinformatic analysis, most of DEPs exhibited hydrolase, oxidoreductase, transferase, ligase, or lyase catalytic activity. DEPs were mainly enriched in metabolic pathways, including metabolism of amino acid, glucose, and carbon. Moreover, 11 of DEPs were involved in exogenous drug and xenobiotics metabolism. Owing to the importance of IDMEs for the efficacy and safety of oral drugs, the expression of cytochrome P450 1A2 (CYP1A2), CYP2D1, CYP3A2, CYP2E1, alcohol dehydrogenase 1 (ADH1), and glutathione S-transferase mu 5 (GSTM5) in rat intestine mucosa was determined by Western-blot. The activity of ADH, aldehyde dehydrogenase (ALDH) and GST was evaluated. Compared with control rats, the expression of CYP1A2, CYP2D1, CYP3A2, and ADH1 in the simulated microgravity (SMG) group of rats were dramatically decreased by 33.16%, 21.93%, 48.49%, and 22.83%, respectively. GSTM5 was significantly upregulated by 53.14% and CYP2E1 expression did not show a dramatical change in SMG group rats. Moreover, 14-day SMG reduced ADH activity, while ALDH and GST activities was not altered remarkably. It could be concluded that SMG dramatically affected the expression and activity of some IDMEs, which might alter the efficacy or safety of their substrate drugs under microgravity. The present study provided some preliminary information on IDMEs under microgravity. It revealed the potential effect of SMG on intestinal metabolism, which may be helpful to understand the intestinal health of astronauts and medication use.

The first central precocious puberty proteomic profiles revealed multiple metabolic networks and novel key disease-associated proteins

“…There are few reports about the role of MLYCD in beta-Alanine metabolism that is known to accelerate oxidation via the peroxisome to inhibit the activity of pyruvate dehydrogenase [ 29 ]. ALDH2 can transform β-aminopropion-aldehyde to β-alanine [ 30 ] and is widely studied as an important cardioprotective factor [ 31 ]. Activate ALDH2 promote mitochondrial homeostasis and suppress mitochondrial ROS (reactive oxygen species) [ 32 , 33 ].…”

Dragon’s Blood Regulates Rac1-WAVE2-Arp2/3 Signaling Pathway to Protect Rat Intestinal Epithelial Barrier Dysfunction Induced by Simulated Microgravity

“…These compounds showed decreased absorption, slower elimination, and double peaks in concentration–time curves in SMG rats. Metabolism of LB in the SMG rat liver microsome; LA, LC, DHF in the human liver microsome, and altered expression of drug-metabolizing enzymes in liver and intestine of SMG rats have been reported in our previous studies [ 58 , 59 , 60 ]. Altered drug-metabolizing enzymes and PK behaviors of DB compounds may be related to the therapeutic effects of DB in SMG rats.…”